CVE-2023-42666

Published: Oct 19, 2023Modified: Nov 21, 2024

5.3

Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Exploitability: 3.9 / Impact: 1.4

Source: NVD

Description

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Affected (1)

Products: Dexma: Dexgate

Dexma

1 product

Dexgate

Configuration A

1 vulnerable

Vulnerable Software	Affected Versions
Dexma Dexgate	Version 20130114

Related CWEs

CWE-200

Exposure of Sensitive Information to an Unauthorized Actor

The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.

References (2)

https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02

Source: ics-cert@hq.dhs.gov

Third Party AdvisoryUS Government Resource

https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02

Source: af854a3a-2127-422b-91ae-364da2661108

Third Party AdvisoryUS Government Resource

Timeline

No history available yet.